Status:
UNKNOWN
Cost Effectiveness if Primary PCI Versus Thrombolytic Therapy in Acute STEMI in Assiut University Hospital
Lead Sponsor:
Nahed Sameh Zaki
Collaborating Sponsors:
Assiut University
Conditions:
ST Elevation Myocardial Infarction
Eligibility:
All Genders
Brief Summary
Cost effectiveness between PPCI and thrombolytic therapy in STEMI patients without contraindications
Detailed Description
Cost effectiveness between PPCI and thrombolytic therapy in STEMI patients 100 patient each within 90 m for PPCI and 6h for thrombolytic
Eligibility Criteria
Inclusion
- All PPCI patients within 90 minutes door to ballon.
- All thrombolytic patient without contraindication ,within 6 golden hours of chest pain.
Exclusion
- patients don't meet inclusion criteria
Key Trial Info
Start Date :
February 7 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2020
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03310437
Start Date
February 7 2018
End Date
October 1 2020
Last Update
July 5 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut medicine faculty
Asyut, Egypt